Business Development
Pubblicato il 17-10-2026 - Birn+Partners in Bari
The Company Sipcam-Oxon is a family-owned Italian multinational group specializing in the chemical and agrochemical sector. Over the years, the Group has expanded across the world’s major agricultural markets, responding to the needs of both global and local customers while pursuing sustainable long-term growth. In all its activities, Sipcam-Oxon places strong emphasis on the specific needs of each territory and on the culture of the communities in which it operates. With nine manufacturing plants worldwide, three of which are located in Italy, Sipcam-Oxon is active in the synthesis of chemical intermediates and active ingredients for the agrochemical and pharmaceutical markets, as well as in renewable power generation and the refining of vegetable and animal feedstocks, which can also be used as precursors for biofuels. With more than 50 years of experience in the industrial-scale production of active ingredients and chemical intermediates, the Fine Chemicals Division operates from its production site in Mezzana Bigli, while corporate coordination is based at the Pero site.
The Division develops innovative synthesis routes for both batch and continuous processes. Its expertise supports the Group’s industrial activities and provides customers with tailor‑made solutions, primarily for the pharmaceutical and agrochemical sectors, while also addressing a broad and growing range of diversified applications. The Division’s capabilities can be leveraged across a wide variety of industries, including industrial cleaning, electronics, food & beverage, and other specialty chemical applications, offering significant opportunities for growth both in Europe and in international markets. Its flexible production capabilities and chemical know‑how enable Sipcam-Oxon to respond to the specific requirements of different industries and market segments. Their strength lies in the continuous search for smart synthesis routes and efficient, integrated processes, aimed at combining produ